We are live on ! Find out more
RPID icon

Rapid Micro Biosystems

42 hedge funds and large institutions have $27.7M invested in Rapid Micro Biosystems in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.21% less ownership

Funds ownership: 70.45%67.24% (-3.2%)

14% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 14

21% less funds holding

Funds holding: 5342 (-11)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

67% less capital invested

Capital invested by funds: $82.8M → $27.7M (-$55.1M)

71% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 14

Holders
42
Holders Change
-11
Holders Change %
-20.75%
% of All Funds
0.68%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
4
Increased
12
Reduced
14
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Tudor Investment Corp
51
Tudor Investment Corp
Connecticut
-$35K -10,760 Closed
Osaic Holdings
52
Osaic Holdings
Arizona
-$1.72K -712 -87%
CUAMC
53
China Universal Asset Management Company
China
-$1K -341 Closed

RPID Hedge Fund Activity: Q4 2022 in Review

42 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q4 2022, worth a combined $27.7M — down 67% from $82.8M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of RPID and 4 opened new positions — a net loss of 10 holders — while 14 trimmed existing stakes and 12 added.

The largest buyer was Goldman Sachs, adding an estimated $2.43M. The largest seller was JP Morgan Chase, cutting an estimated $3.42M.

  • 42 institutional investors held Rapid Micro Biosystems (RPID) as of Q4 2022, down from 53 in Q3 2022.
  • Funds reported $27.7M of Rapid Micro Biosystems stock for Q4 2022, down 67% quarter-over-quarter.
  • 4 funds opened new Rapid Micro Biosystems positions in Q4 2022 and 14 closed out, a net change of -10 holders.
  • The largest Rapid Micro Biosystems buyer in Q4 2022 was Goldman Sachs, an estimated $2.43M added.
  • The largest Rapid Micro Biosystems seller in Q4 2022 was JP Morgan Chase, an estimated $3.42M sold.

Based on aggregated 13F filings for Q4 2022.